{"id":"https://openalex.org/W4386913489","doi":"https://doi.org/10.24304/kjcp.2023.33.3.178","title":"Matching-adjusted Indirect Comparison (MAIC) of Tralokinumab Versus Dupilumab for the Treatment of Moderate to Severe Adult Atopic Dermatitis","display_name":"Matching-adjusted Indirect Comparison (MAIC) of Tralokinumab Versus Dupilumab for the Treatment of Moderate to Severe Adult Atopic Dermatitis","publication_year":2023,"publication_date":"2023-09-22","ids":{"openalex":"https://openalex.org/W4386913489","doi":"https://doi.org/10.24304/kjcp.2023.33.3.178"},"language":"en","primary_location":{"id":"doi:10.24304/kjcp.2023.33.3.178","doi":"https://doi.org/10.24304/kjcp.2023.33.3.178","is_oa":true,"landing_page_url":"http://dx.doi.org/10.24304/kjcp.2023.33.3.178","pdf_url":"https://www.ekjcp.org/journal/download_pdf.php?doi=10.24304/kjcp.2023.33.3.178","source":{"id":"https://openalex.org/S4306517643","display_name":"Korean Journal of Clinical Pharmacy","issn_l":"1226-6051","issn":["1226-6051","1975-1869","2508-786X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["kci-registered"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Korean Journal of Clinical Pharmacy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.ekjcp.org/journal/download_pdf.php?doi=10.24304/kjcp.2023.33.3.178","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Taekyung Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Taekyung Kim","raw_affiliation_strings":["Department of Statistics and Data Science, Department of Applied Statistics, Yonsei University, Seoul 03722, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Statistics and Data Science, Department of Applied Statistics, Yonsei University, Seoul 03722, Republic of Korea","institution_ids":["https://openalex.org/I193775966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104171852","display_name":"Keun Soo Shin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keun Soo Shin","raw_affiliation_strings":["Market Access, LEO Pharma Inc., Seoul 04520, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Market Access, LEO Pharma Inc., Seoul 04520, Republic of Korea","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100439171","display_name":"Hyojin Kim","orcid":"https://orcid.org/0000-0003-0987-4938","observed_orcids":["https://orcid.org/0000-0003-0987-4938"]},"institutions":[{"id":"https://openalex.org/I4210121423","display_name":"Syneos Health (South Korea)","ror":"https://ror.org/02fq4hx73","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210121423"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Hyojin Kim","raw_affiliation_strings":["RWE, Syneos Health Korea, Seoul 06133, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RWE, Syneos Health Korea, Seoul 06133, Republic of Korea","institution_ids":["https://openalex.org/I4210121423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102826378","display_name":"Eugene Kim","orcid":"https://orcid.org/0000-0001-7618-6719","observed_orcids":["https://orcid.org/0000-0001-7618-6719"]},"institutions":[{"id":"https://openalex.org/I4210121423","display_name":"Syneos Health (South Korea)","ror":"https://ror.org/02fq4hx73","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210121423"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Eugene Kim","raw_affiliation_strings":["RWE, Syneos Health Korea, Seoul 06133, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RWE, Syneos Health Korea, Seoul 06133, Republic of Korea","institution_ids":["https://openalex.org/I4210121423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062283757","display_name":"Leejung Choi","orcid":"https://orcid.org/0000-0002-5599-4554","observed_orcids":["https://orcid.org/0000-0002-5599-4554"]},"institutions":[{"id":"https://openalex.org/I4210121423","display_name":"Syneos Health (South Korea)","ror":"https://ror.org/02fq4hx73","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210121423"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Leejung Choi","raw_affiliation_strings":["RWE, Syneos Health Korea, Seoul 06133, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RWE, Syneos Health Korea, Seoul 06133, Republic of Korea","institution_ids":["https://openalex.org/I4210121423"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100370205","display_name":"Dong Hun Lee","orcid":"https://orcid.org/0000-0002-2925-3074","observed_orcids":["https://orcid.org/0000-0002-2925-3074","https://orcid.org/0009-0000-9114-4234"]},"institutions":[{"id":"https://openalex.org/I2802835388","display_name":"Seoul National University Hospital","ror":"https://ror.org/01z4nnt86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}],"countries":["KR"],"is_corresponding":true,"raw_author_name":"Dong Hun Lee","raw_affiliation_strings":["Department of Dermatology, Seoul National University Hospital, Seoul 03080, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Seoul National University Hospital, Seoul 03080, Republic of Korea","institution_ids":["https://openalex.org/I2802835388"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5100370205"],"corresponding_institution_ids":["https://openalex.org/I2802835388"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"3","first_page":"178","last_page":"185"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.921999990940094},{"id":"https://openalex.org/keywords/tralokinumab","display_name":"tralokinumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dupilumab","display_name":"dupilumab","score":1.0},{"id":"https://openalex.org/keywords/matching-adjusted-indirect-comparison","display_name":"matching-adjusted indirect comparison","score":0.8539999723434448},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.9580000042915344},{"id":"https://openalex.org/keywords/eczema-area-and-severity-index","display_name":"Eczema Area and Severity Index","score":0.9359999895095825},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.7429999709129333},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.46399998664855957}],"concepts":[{"id":"https://openalex.org/C2779824493","wikidata":"https://www.wikidata.org/wiki/Q5315925","display_name":"Dupilumab","level":3,"score":0.9785950183868408},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.7999023199081421},{"id":"https://openalex.org/C165064840","wikidata":"https://www.wikidata.org/wiki/Q1321061","display_name":"Matching (statistics)","level":2,"score":0.6386862993240356},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5123623609542847},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.47094666957855225},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06318828463554382}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.24304/kjcp.2023.33.3.178","doi":"https://doi.org/10.24304/kjcp.2023.33.3.178","is_oa":true,"landing_page_url":"http://dx.doi.org/10.24304/kjcp.2023.33.3.178","pdf_url":"https://www.ekjcp.org/journal/download_pdf.php?doi=10.24304/kjcp.2023.33.3.178","source":{"id":"https://openalex.org/S4306517643","display_name":"Korean Journal of Clinical Pharmacy","issn_l":"1226-6051","issn":["1226-6051","1975-1869","2508-786X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["kci-registered"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Korean Journal of Clinical Pharmacy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.24304/kjcp.2023.33.3.178","doi":"https://doi.org/10.24304/kjcp.2023.33.3.178","is_oa":true,"landing_page_url":"http://dx.doi.org/10.24304/kjcp.2023.33.3.178","pdf_url":"https://www.ekjcp.org/journal/download_pdf.php?doi=10.24304/kjcp.2023.33.3.178","source":{"id":"https://openalex.org/S4306517643","display_name":"Korean Journal of Clinical Pharmacy","issn_l":"1226-6051","issn":["1226-6051","1975-1869","2508-786X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["kci-registered"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Korean Journal of Clinical Pharmacy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386913489.pdf","grobid_xml":"https://content.openalex.org/works/W4386913489.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1931149717","https://openalex.org/W2029005903","https://openalex.org/W2083085391","https://openalex.org/W2092901728","https://openalex.org/W2771011851","https://openalex.org/W2952535698","https://openalex.org/W2989041533","https://openalex.org/W3096988120","https://openalex.org/W3107022845","https://openalex.org/W3163293937","https://openalex.org/W3198362992","https://openalex.org/W3209422551","https://openalex.org/W4238573029","https://openalex.org/W4280493018","https://openalex.org/W4285077650","https://openalex.org/W4286515998","https://openalex.org/W4288050640","https://openalex.org/W4292684063","https://openalex.org/W4360599743"],"related_works":["https://openalex.org/W4390904793","https://openalex.org/W4394785038","https://openalex.org/W4393005643","https://openalex.org/W7215976389","https://openalex.org/W7154155935","https://openalex.org/W4404455277","https://openalex.org/W4405748586","https://openalex.org/W4390904736","https://openalex.org/W4410206751","https://openalex.org/W4393005622"],"abstract_inverted_index":{"Objective:":[0],"Atopic":[1],"dermatitis":[2],"(AD)":[3],"is":[4,50,165,168,217],"a":[5,80,120,198,230],"chronic,":[6],"recurrent":[7],"inflammatory":[8],"skin":[9],"disease.Both":[10],"tralokinumab":[11,56,90,146,167,190,202,216],"and":[12,42,57,93,127,147,191,203,221],"dupilumab":[13,31,100,148,172,192,204,220],"have":[14],"been":[15,33],"recommended":[16],"in":[17,68,137,183,225],"the":[18,22,65,89,99,105,124,138,156,160,174,178,181,184],"European":[19],"Guideline":[20],"for":[21,35,44,76,88,98,159,180],"treatment":[23,111],"of":[24,140,177,211],"adult":[25],"patients":[26,36,69,118,141],"with":[27,37,46,70,229],"severe":[28,40,47],"AD.In":[29],"Korea,":[30],"has":[32],"approved":[34],"moderate":[38],"to":[39,63,154,171,219,234],"AD,":[41],"reimbursed":[43],"those":[45],"AD.Since":[48],"there":[49],"no":[51],"clinical":[52,66,74,91,101,227],"trial":[53],"directly":[54],"comparing":[55,201],"dupilumab,":[58],"we":[59,103],"conducted":[60,197],"indirect":[61,77],"comparison":[62,78],"assess":[64],"usefulness":[67],"AD.Methods:":[71],"We":[72,196],"selected":[73],"trials":[75],"through":[79],"systematic":[81],"literature":[82],"review.Individual":[83],"patient":[84],"data":[85,95],"were":[86,96],"available":[87,97],"trial,":[92],"aggregated":[94],"trial.Therefore,":[102],"employed":[104],"Matching-Adjusted":[106],"Indirect":[107],"Comparison":[108],"(MAIC)":[109],"method.The":[110],"efficacy":[112],"was":[113,149,193],"assessed":[114],"based":[115,205],"on":[116,123,206],"whether":[117],"achieved":[119],"75%":[121],"reduction":[122],"Eczema":[125],"Area":[126],"Severity":[128],"Index":[129],"(EASI":[130],"75)":[131],"after":[132],"drug":[133],"administration.Results:":[134],"The":[135],"difference":[136,182],"proportion":[139],"achieving":[142],"EASI":[143,161,185,207],"75":[144,162,186,208],"between":[145,189],"4.7%":[150],"(95%":[151],"CI:":[152],"-7.9":[153],"17.3).Considering":[155],"non-inferiority":[157],"margin":[158],"achievement":[163,187],"rate":[164,188],"-10%,":[166],"deemed":[169],"non-inferior":[170,218],"as":[173],"lower":[175],"bound":[176],"CI":[179],"within":[194],"-10%.Conclusion:":[195],"MAIC":[199],"analysis":[200],"achievement.The":[209],"findings":[210],"this":[212],"study":[213],"show":[214],"that":[215],"can":[222],"be":[223],"implemented":[224],"Korean":[226],"settings":[228],"therapeutic":[231],"position":[232],"comparable":[233],"dupilumab.":[235]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-09-22T00:00:00"}